1. Home
  2. SLS vs HLP Comparison

SLS vs HLP Comparison

Compare SLS & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • HLP
  • Stock Information
  • Founded
  • SLS 2012
  • HLP 2021
  • Country
  • SLS United States
  • HLP China
  • Employees
  • SLS N/A
  • HLP N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • HLP Industrial Machinery/Components
  • Sector
  • SLS Health Care
  • HLP Industrials
  • Exchange
  • SLS Nasdaq
  • HLP Nasdaq
  • Market Cap
  • SLS 89.6M
  • HLP 94.0M
  • IPO Year
  • SLS N/A
  • HLP 2023
  • Fundamental
  • Price
  • SLS $1.09
  • HLP $1.23
  • Analyst Decision
  • SLS
  • HLP
  • Analyst Count
  • SLS 0
  • HLP 0
  • Target Price
  • SLS N/A
  • HLP N/A
  • AVG Volume (30 Days)
  • SLS 815.8K
  • HLP 18.7K
  • Earning Date
  • SLS 03-20-2025
  • HLP 04-08-2025
  • Dividend Yield
  • SLS N/A
  • HLP N/A
  • EPS Growth
  • SLS N/A
  • HLP N/A
  • EPS
  • SLS N/A
  • HLP N/A
  • Revenue
  • SLS N/A
  • HLP $14,045,084.00
  • Revenue This Year
  • SLS N/A
  • HLP N/A
  • Revenue Next Year
  • SLS N/A
  • HLP N/A
  • P/E Ratio
  • SLS N/A
  • HLP N/A
  • Revenue Growth
  • SLS N/A
  • HLP N/A
  • 52 Week Low
  • SLS $0.77
  • HLP $1.00
  • 52 Week High
  • SLS $1.84
  • HLP $2.25
  • Technical
  • Relative Strength Index (RSI)
  • SLS 40.56
  • HLP 36.11
  • Support Level
  • SLS $1.13
  • HLP $1.28
  • Resistance Level
  • SLS $1.25
  • HLP $1.31
  • Average True Range (ATR)
  • SLS 0.07
  • HLP 0.04
  • MACD
  • SLS -0.01
  • HLP -0.01
  • Stochastic Oscillator
  • SLS 17.39
  • HLP 0.00

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About HLP Hongli Group Inc.

Hongli Group Inc is a cold roll formed steel profile manufacturer in China. It customizes and manufactures cold roll formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture and transportation.

Share on Social Networks: